Venous ulcer treatment sales will strengthen through 2036, anchored by venous ulcers at 46.8% of the disease type in 2026. The market was valued at USD 3.36 billion in 2025 and is expected to be worth USD 6.57 billion by 2036, creating an incremental opportunity of USD 3.00 billion.